Could Testosterone Help Your Low Libido After Menopause?

If your sex drive has quietly disappeared somewhere in perimenopause or menopause — and it bothers you — you're not imagining it, and you're not alone. This is one of the most common, least discussed symptoms women bring up in midlife care, usually after they've already tried "just relax more" advice that didn't work.

The goal for most women asking about this: get their desire, arousal, and satisfaction back to something that feels like them again — not chase a lab number.

What is HSDD, in plain language?

Hypoactive Sexual Desire Disorder (HSDD) means a persistent, distressing drop in sexual desire — distressing being the key word. A lower sex drive that doesn't bother you isn't a disorder. A lower sex drive that does bother you, and has lasted a while, is worth treating.

Testosterone is a hormone your ovaries and adrenal glands make throughout your life. Levels decline gradually with age — by menopause, many women have roughly half the circulating testosterone they had in their 20s. Transdermal testosterone (a cream, gel, or patch absorbed through the skin) is one option used to bring that back into a normal physiologic range.

The evidence: what's proven vs. promising

Proven — sexual desire, arousal, and satisfaction. Two major systematic reviews and meta-analyses (pooled data from dozens of randomized controlled trials, not single studies) have looked at this question directly. The most comprehensive, published in The Lancet Diabetes & Endocrinology in 2019, pooled data from 36 RCTs and found consistent, statistically significant improvements in satisfying sexual events, desire, arousal, and pleasure compared with placebo. An earlier review focused specifically on the testosterone patch found an extra satisfying sexual event roughly every month compared with placebo.

This is now considered strong enough evidence that major medical societies (including the International Society for the Study of Women's Sexual Health) recommend transdermal testosterone as a treatment option for postmenopausal women with HSDD.

Promising, not yet proven — energy and mood. Many women report feeling more energetic on testosterone therapy, and there's a biological reason that's plausible: low testosterone is linked to fatigue and low mood in general. But when researchers pooled the actual randomized trial data, the evidence wasn't strong enough to say testosterone reliably improves energy, mood, or cognition on its own. That may change as more research comes in — for now, treat improved energy as a possible bonus, not a guaranteed outcome, and don't let it be the sole reason for starting treatment.

The upside

• Meaningful, well-documented improvement in desire, arousal, and sexual satisfaction for women with HSDD

  
  

• Transdermal (skin-applied) delivery avoids the negative cholesterol effects seen with oral testosterone

  
  

• No serious safety signals identified in the trial data reviewed — short-term studies show a good safety profile

The limits

• No testosterone product is FDA-approved for women in the U.S., so this is always an off-label, shared-decision conversation

  
  

• The most common side effects are androgenic — acne, extra hair growth — usually dose-related and reversible

  
  

• Long-term safety data (beyond a few years) and data on compounded (custom-mixed) preparations specifically are limited; guidelines currently recommend against compounded testosterone for this reason and favor carefully dosed, government-approved male formulations used at female-appropriate doses

  
  

• It's not a fix for desire issues rooted in relationship stress, sleep deprivation, depression, or medication side effects — those need their own workup first

Who this is for — and who should pause

Good candidate: a postmenopausal woman with persistent, distressing low sexual desire, once other causes (thyroid, depression, medications, relationship or life stress, vaginal dryness/pain) have been considered and addressed.

Worth a pause or a different conversation first: active or suspected hormone-sensitive cancer, unexplained abnormal bleeding, or significant untreated cardiovascular risk factors — these need individualized discussion before starting.

One next step

If low desire has been quietly bothering you, the first move isn't a prescription — it's a real conversation and a baseline hormone panel, so we know where you're starting from and can rule out the more common, more fixable culprits first.

Testosterone can be part of a bigger picture that also includes sleep quality, muscle-supportive nutrition, and metabolic health — all of which affect desire and energy long before hormones become the main lever. If you want to talk through where you're at, that's exactly the kind of conversation a DPC membership makes room for.

General wellness education only. Not medical advice. Does not establish a physician-patient relationship.